Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

New Anti-HIV Drugs Receive FDA Approval

October 2003

Three anti-HIV drugs have recently been approved by the Food and Drug Administration, including one in a new class called fusion or entry inhibitor. Each adds something unique to the arsenal of therapies to treat HIV infection. The three include:


Drug NameTrade NameCompanyDrug Class
T-20, enfuvirtideFuzeonHoffman La-Roche, Trimerisentry inhibitor
FTC, emtricitabineEmtrivaGileadnucleoside analog reverse transcriptase inhibitor
AtazanavirReyatazBristol-Myers Squibbprotease inhibitor


The following articles highlight information on each of the newly approved drugs and provide a discussion on how they fit into the arsenal of existing drugs.


Back to the Project Inform Perspective October 2003 contents page.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by Project Inform. It is a part of the publication Project Inform Perspective. Visit Project Inform's website to find out more about their activities, publications and services.
 

Tools
 

Advertisement